Skip to main content

Advertisement

Table 2 Multivariate analysis of factors associated with time to death for the study cohort (402 patients) with available data for the entire follow-up period*

From: Therapy duration and long-term outcomes in extra-pulmonary tuberculosis

Variable Hazard ratio (95% CI) P-value
Age (years)   
18 – 24 Referent  
25 – 34 2.75 (0.60, 12.59) 0.19
35 – 44 2.08 (0.46, 9.44) 0.34
45 – 54 2.42 (0.54, 10.85) 0.25
55 – 64 2.02 (0.42, 9.66) 0.38
65 – 74 3.71 (0.77, 17.79) 0.10
>75 7.43 (1.54, 35.93) 0.01
HIV-infected versus non-infected 2.16 (1.22, 3.83) <0.01
Male 1.52 (1.01, 2.72) 0.04
TB disease site   
Meningeal Referent  
Lymphatic 0.50 (0.27, 0.91) 0.02
Bone/joint 0.42 (0.21, 0.81) 0.01
Peritoneal 0.59 (0.27, 1.31) 0.20
Other sites 0.47 (0.23, 0.97) 0.04
Therapy duration   
6-months Referent  
<6-months 2.72 (1.34, 5.50) <0.01
7 – 10 months 1.63 (0.85, 3.12) 0.14
>10-months 1.52 (0.75, 3.10) 0.25
  1. *Multivariate regression analysis drops patients with missing variables, so the final model comprised of 402 instead of 438 patients.